The Medicines Company, Alnylam Announce Advance Development Candidate for Treatment of Hypercholesterolemia
October 09, 2013 at 06:10 AM EDT
The Medicines Company (NASDAQ: MDCO ) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) announced today that their strategic alliance has yielded a lead Development Candidate that is